Medical - Distribution
Compare Stocks
2 / 10Stock Comparison
HSIC vs DXPE
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Distribution
HSIC vs DXPE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Distribution | Industrial - Distribution |
| Market Cap | $8.13B | $2.42B |
| Revenue (TTM) | $13.18B | $2.06B |
| Net Income (TTM) | $398M | $88M |
| Gross Margin | 29.1% | 31.7% |
| Operating Margin | 5.8% | 8.7% |
| Forward P/E | 13.2x | 25.5x |
| Total Debt | $3.69B | $982M |
| Cash & Equiv. | $156M | $304M |
HSIC vs DXPE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Henry Schein, Inc. (HSIC) | 100 | 116.6 | +16.6% |
| DXP Enterprises, In… (DXPE) | 100 | 885.9 | +785.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HSIC vs DXPE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HSIC is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.72
- Lower volatility, beta 0.72, Low D/E 76.9%, current ratio 1.38x
- Beta 0.72, current ratio 1.38x
DXPE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 11.9%, EPS growth 27.0%, 3Y rev CAGR 10.8%
- 7.3% 10Y total return vs HSIC's 5.8%
- 11.9% revenue growth vs HSIC's 4.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% revenue growth vs HSIC's 4.0% | |
| Value | Lower P/E (13.2x vs 25.5x) | |
| Quality / Margins | 4.3% margin vs HSIC's 3.0% | |
| Stability / Safety | Beta 0.72 vs DXPE's 1.70, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +80.6% vs HSIC's +2.8% | |
| Efficiency (ROA) | 5.6% ROA vs HSIC's 3.6%, ROIC 12.5% vs 7.1% |
HSIC vs DXPE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HSIC vs DXPE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DXPE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HSIC is the larger business by revenue, generating $13.2B annually — 6.4x DXPE's $2.1B. Profitability is closely matched — net margins range from 4.3% (DXPE) to 3.0% (HSIC).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $13.2B | $2.1B |
| EBITDAEarnings before interest/tax | $1.1B | $209M |
| Net IncomeAfter-tax profit | $398M | $88M |
| Free Cash FlowCash after capex | $561M | $71M |
| Gross MarginGross profit ÷ Revenue | +29.1% | +31.7% |
| Operating MarginEBIT ÷ Revenue | +5.8% | +8.7% |
| Net MarginNet income ÷ Revenue | +3.0% | +4.3% |
| FCF MarginFCF ÷ Revenue | +4.3% | +3.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.7% | +9.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.9% | -2.4% |
Valuation Metrics
HSIC leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 21.7x trailing earnings, HSIC trades at a 26% valuation discount to DXPE's 29.1x P/E. On an enterprise value basis, HSIC's 10.9x EV/EBITDA is more attractive than DXPE's 14.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $8.1B | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $11.7B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 21.66x | 29.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.25x | 25.52x |
| PEG RatioP/E ÷ EPS growth rate | 6.87x | — |
| EV / EBITDAEnterprise value multiple | 10.90x | 14.38x |
| Price / SalesMarket cap ÷ Revenue | 0.62x | 1.20x |
| Price / BookPrice ÷ Book value/share | 1.80x | 5.15x |
| Price / FCFMarket cap ÷ FCF | 14.18x | 44.91x |
Profitability & Efficiency
DXPE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
DXPE delivers a 17.9% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $8 for HSIC. HSIC carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to DXPE's 1.97x. On the Piotroski fundamental quality scale (0–9), DXPE scores 7/9 vs HSIC's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.2% | +17.9% |
| ROA (TTM)Return on assets | +3.6% | +5.6% |
| ROICReturn on invested capital | +7.1% | +12.5% |
| ROCEReturn on capital employed | +9.8% | +14.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.77x | 1.97x |
| Net DebtTotal debt minus cash | $3.5B | $678M |
| Cash & Equiv.Liquid assets | $156M | $304M |
| Total DebtShort + long-term debt | $3.7B | $982M |
| Interest CoverageEBIT ÷ Interest expense | 4.59x | 2.89x |
Total Returns (Dividends Reinvested)
DXPE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DXPE five years ago would be worth $48,898 today (with dividends reinvested), compared to $8,536 for HSIC. Over the past 12 months, DXPE leads with a +80.6% total return vs HSIC's +2.8%. The 3-year compound annual growth rate (CAGR) favors DXPE at 85.5% vs HSIC's -3.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -7.8% | +45.0% |
| 1-Year ReturnPast 12 months | +2.8% | +80.6% |
| 3-Year ReturnCumulative with dividends | -11.3% | +538.5% |
| 5-Year ReturnCumulative with dividends | -14.6% | +389.0% |
| 10-Year ReturnCumulative with dividends | +5.8% | +732.1% |
| CAGR (3Y)Annualised 3-year return | -3.9% | +85.5% |
Risk & Volatility
Evenly matched — HSIC and DXPE each lead in 1 of 2 comparable metrics.
Risk & Volatility
HSIC is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than DXPE's 1.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DXPE currently trades 85.0% from its 52-week high vs HSIC's 79.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 1.70x |
| 52-Week HighHighest price in past year | $89.29 | $183.76 |
| 52-Week LowLowest price in past year | $61.95 | $75.58 |
| % of 52W HighCurrent price vs 52-week peak | +79.3% | +85.0% |
| RSI (14)Momentum oscillator 0–100 | 34.3 | 42.7 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 175K |
Analyst Outlook
DXPE leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates HSIC as "Hold" and DXPE as "Hold". Consensus price targets imply 20.6% upside for HSIC (target: $85) vs -1.4% for DXPE (target: $154).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $85.43 | $154.00 |
| # AnalystsCovering analysts | 32 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% |
| Dividend StreakConsecutive years of raises | 1 | 4 |
| Dividend / ShareAnnual DPS | — | $0.01 |
| Buyback YieldShare repurchases ÷ mkt cap | +10.5% | +0.7% |
DXPE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HSIC leads in 1 (Valuation Metrics). 1 tied.
HSIC vs DXPE: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HSIC or DXPE a better buy right now?
For growth investors, DXP Enterprises, Inc.
(DXPE) is the stronger pick with 11. 9% revenue growth year-over-year, versus 4. 0% for Henry Schein, Inc. (HSIC). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Henry Schein, Inc. (HSIC) a "Hold" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HSIC or DXPE?
On trailing P/E, Henry Schein, Inc.
(HSIC) is the cheapest at 21. 7x versus DXP Enterprises, Inc. at 29. 1x. On forward P/E, Henry Schein, Inc. is actually cheaper at 13. 2x.
03Which is the better long-term investment — HSIC or DXPE?
Over the past 5 years, DXP Enterprises, Inc.
(DXPE) delivered a total return of +389. 0%, compared to -14. 6% for Henry Schein, Inc. (HSIC). Over 10 years, the gap is even starker: DXPE returned +732. 1% versus HSIC's +5. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HSIC or DXPE?
By beta (market sensitivity over 5 years), Henry Schein, Inc.
(HSIC) is the lower-risk stock at 0. 72β versus DXP Enterprises, Inc. 's 1. 70β — meaning DXPE is approximately 134% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Henry Schein, Inc. (HSIC) carries a lower debt/equity ratio of 77% versus 197% for DXP Enterprises, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HSIC or DXPE?
By revenue growth (latest reported year), DXP Enterprises, Inc.
(DXPE) is pulling ahead at 11. 9% versus 4. 0% for Henry Schein, Inc. (HSIC). On earnings-per-share growth, the picture is similar: DXP Enterprises, Inc. grew EPS 27. 0% year-over-year, compared to 7. 2% for Henry Schein, Inc.. Over a 3-year CAGR, DXPE leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HSIC or DXPE?
DXP Enterprises, Inc.
(DXPE) is the more profitable company, earning 4. 4% net margin versus 3. 0% for Henry Schein, Inc. — meaning it keeps 4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXPE leads at 8. 8% versus 5. 7% for HSIC. At the gross margin level — before operating expenses — DXPE leads at 31. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HSIC or DXPE more undervalued right now?
On forward earnings alone, Henry Schein, Inc.
(HSIC) trades at 13. 2x forward P/E versus 25. 5x for DXP Enterprises, Inc. — 12. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HSIC: 20. 6% to $85. 43.
08Which pays a better dividend — HSIC or DXPE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is HSIC or DXPE better for a retirement portfolio?
For long-horizon retirement investors, Henry Schein, Inc.
(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). DXP Enterprises, Inc. (DXPE) carries a higher beta of 1. 70 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HSIC: +5. 8%, DXPE: +732. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HSIC and DXPE?
These companies operate in different sectors (HSIC (Healthcare) and DXPE (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.